Latest Updates

JOURNAL CLUB

Journal Club selections are curated by the Kidney Cancer Journal editorial team based on clinical significance, study design rigor, and potential impact on practice. Full-text access available via PubMed and respective journal platforms. Belzutifan plus lenvatinib versus cabozantinib in patients with previously…

Latest Issue Latest Updates by KidNEYCAnCeR October 10, 2026

78Views 0Comments

Stereotactic Body Radiotherapy for Primary Renal Tumors: Technological Evolution, Current Evidence and Practical Recommendations

1. Introduction and Background Renal cell carcinoma (RCC) is frequently detected incidentally on imaging tests performed for other reasons, and its incidence continues to increase, particularly in the elderly (1). Although surgical resection of the tumor remains the treatment of choice…

Editor's Memo Latest Updates by KidNEYCAnCeR October 10, 2026

63Views 0Comments

The Adjuvant Reckoning: Belzutifan,Toxicity, and the Next Phase of RCC Care

Dear Colleagues, This has been an unusually productive stretch for renal cell carcinoma (RCC) research, and the Third Quarter 2026 issue of Kidney Cancer Journal reflects that momentum. Between the follow-through from ASCO's Genitourinary Cancers Symposium earlier this year and the full…

Latest Updates by KidNEYCAnCeR June 17, 2026

624Views 0Comments

Management of Carcinoid Tumor within a Horseshoe Kidney

Andrea Lopez Sanmiguel1, Dilara Akbulut1, Jeff Chen1, Yash S. Khandwala1, Paul Russo1† Affiliations: 1 Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY Abstract Horseshoe kidney is the most common renal fusion…

2026 ASCO Latest Updates by KidNEYCAnCeR June 17, 2026

3109Views 0Comments

The Architecture of a Cure: Where Renal Cell Carcinoma Research Stands in 2026

Thomas E. Hutson, DO, PharmD, FACP EDITORIAL NOTE | Editor-in-Chief, Kidney Cancer Journal There is a particular kind of optimism that belongs only to a field in the midst of genuine transformation…

Articles Latest Updates by KidNEYCAnCeR June 15, 2026

3792Views 0Comments

Most Clinically Significant Kidney Cancer Presentations from ASCO 2026

Selected by the Editor-in-Chief | Kidney Cancer Journal, Volume 24(2) Primary data drawn from ASCO 2026 presentations, JCO supplement abstracts, press releases, and peer-reviewed commentary. Abstract 1 — LBA418 LITESPARK-022: Pembrolizumab Plus Belzutifan Versus Pembrolizumab Plus Placebo as Adjuvant Therapy for Clear…

955Views 0Comments

Journal Club

Significant Recent Publications in Kidney Cancer Curated by the Editorial Team, Kidney Cancer Journal | Volume 24(2) Includes clinical trials and randomized controlled trials published within the past 10 weeks in high-impact peer-reviewed journals. █ CheckMate 9ER Final Analysis:…

Latest Updates

JOURNAL CLUB

Stereotactic Body Radiotherapy for Primary Renal Tumors: Technological Evolution, Current Evidence and Practical Recommendations

The Adjuvant Reckoning: Belzutifan,Toxicity, and the Next Phase of RCC Care

Management of Carcinoid Tumor within a Horseshoe Kidney

The Architecture of a Cure: Where Renal Cell Carcinoma Research Stands in 2026

Most Clinically Significant Kidney Cancer Presentations from ASCO 2026

Journal Club

About Us

Contents

Follow Us

Guidelines

Patient Resources